Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial BioTech February 11, 2021 Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment Novamind Inc. (CSE:NM) (“Novamind”), a…
